In The News
Upcoming Events
Patient Resources
Galil Medical Minimally Invasive Cryotherapy Solutions
 
 
OnDemand Media Center A Look at Galil Medical
 
 

Home  |  Press Releases  |  About Galil Medical  |  Investor Relations  |  Contacts  |  Customer Support

   

PROSTATE CANCER
CRYOTHERAPY

KIDNEY CANCER
CRYOTHERAPY

IMAGE-GUIDED
CRYOABLATION

CRYOABLATION
TECHNOLOGY

CRYOABLATION
PRODUCTS

 

Prostate Cancer Statistics and Survival Rates

Among men in the United States, prostate cancer is the most common cancer, next to skin cancer. Prostate cancer statistics, according to the American Cancer Society, indicate that for 2009, about 192,280 new cases of prostate cancer will be diagnosed and 27,360 men will die of prostate cancer.1

These numbers can also be expressed as 1 in 6 men will be diagnosed with prostate cancer during their lifetime and 1 in 35 men will die of prostate cancer. Second only to lung cancer, prostate cancer is a leading cause of cancer death in American men and the disease accounts for about 10% of cancer-related deaths in men overall.1 That said, more than 2 million men in the United States who have been diagnosed with prostate cancer at some point are still alive today.1

A 5-year survival rate can be defined as the percentage of patients diagnosed and first treated more than 5 years ago and who live at least 5 years after their cancer is diagnosed. Many patients live much longer than 5 years after diagnosis. Five-year survival rates are used among medical professionals to create a standard way of discussing prognosis (or outlook) for patients with a certain cancer. These rates compare the recently observed survival with that expected for people without cancer, so that relative survival only reflects the number of deaths from the cancer in question. Improvements in prostate cancer treatment since a patient was first treated may result in a better outlook for recently diagnosed patients.

The American Cancer Society prostate cancer statistics also indicate that of all men with prostate cancer, the relative 5-year survival rate is nearly 100%, the relative 10-year survival rate is 91%, and the relative 15-year survival rate is 76%.1 It is important to remember that 5-year survival rates are based on patients diagnosed and first treated more than 5 years ago, and 10-year survival rates are based on patients diagnosed more than 10 years ago. Advanced methods of detection and prostate cancer treatment mean that many prostate cancers are now found earlier and can be treated more effectively. If you are among the many men diagnosed with prostate cancer this year, your prognosis (or outlook) is likely to be better than the number reported above.

1 Detailed Guide: Prostate Cancer “What Are the Key Statistics About Prostate Cancer.” American Cancer Society, July 30 ,2009.

 
 
 
 
 

© 2007 Galil Medical. All rights reserved.
Site Map | Disclaimers—Terms of Use | Glossary | More Information | HIPPA | Employees | Physicians
In The News | Upcoming Events | Patient Resources | OnDemand Media Center
Website Design by DDA Medical